Bendamustine Plus Rituximab Followed By Rituximab Maintenance for Patients with Untreated Advanced Follicular Lymphomas. Results from the StiL NHL 7-2008 Trial (MAINTAIN trial) (ClinicalTrials.gov Identifier: NCT00877214)
Mathias Rummel(Universitätsklinikum Gießen und Marburg), Wolfram Brugger(University of Freiburg), Arnold Ganser(Medizinische Hochschule Hannover), Axel Matzdorff(cts CaritasKlinikum Saarbrücken), Alexander Burchardt(Johannes Gutenberg University Mainz), Heinz Dürk(St. Marien Hospital), Richard Greil(Paracelsus Medical University), Manfred Reeb, Bernd Hertenstein(San Antonio College), Christina Balser(Philipps University of Marburg), Frank Kauff(Justus-Liebig-Universität Gießen), Andreas Viardot(University Hospital Ulm), Ulrich Kaiser(University of Applied Sciences Landshut), Georg Maschmeyer(Radboud University Medical Center), Axel Hinke, Wolfgang Blau(Universitätsklinikum Gießen und Marburg), Jürgen Barth(Justus-Liebig-Universität Gießen), Georg Schliesser, Christian Lerchenmüller, Jan Dürig(Essen University Hospital), Tobias Gaska(Brüderkrankenhaus St. Josef Paderborn), Rudolf Weide
Cited by 7
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k